NO20023345D0 - Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem - Google Patents
Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende demInfo
- Publication number
- NO20023345D0 NO20023345D0 NO20023345A NO20023345A NO20023345D0 NO 20023345 D0 NO20023345 D0 NO 20023345D0 NO 20023345 A NO20023345 A NO 20023345A NO 20023345 A NO20023345 A NO 20023345A NO 20023345 D0 NO20023345 D0 NO 20023345D0
- Authority
- NO
- Norway
- Prior art keywords
- pyrido
- preparation
- pharmaceutical compositions
- compositions containing
- pyrazine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0109260A FR2827288B1 (fr) | 2001-07-12 | 2001-07-12 | Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20023345D0 true NO20023345D0 (no) | 2002-07-11 |
NO20023345L NO20023345L (no) | 2003-01-13 |
NO322966B1 NO322966B1 (no) | 2006-12-18 |
Family
ID=8865405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20023345A NO322966B1 (no) | 2001-07-12 | 2002-07-11 | Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (25)
Country | Link |
---|---|
US (1) | US6992085B2 (no) |
EP (1) | EP1275647B1 (no) |
JP (1) | JP3950018B2 (no) |
KR (1) | KR100485020B1 (no) |
CN (1) | CN1197863C (no) |
AR (1) | AR036166A1 (no) |
AT (1) | ATE254124T1 (no) |
AU (1) | AU2002300094B2 (no) |
BR (1) | BR0202681A (no) |
CA (1) | CA2394027C (no) |
DE (1) | DE60200089T2 (no) |
DK (1) | DK1275647T3 (no) |
EA (1) | EA005160B1 (no) |
ES (1) | ES2210219T3 (no) |
FR (1) | FR2827288B1 (no) |
HK (1) | HK1050682A1 (no) |
HU (1) | HUP0202282A3 (no) |
MX (1) | MXPA02006699A (no) |
NO (1) | NO322966B1 (no) |
NZ (1) | NZ520120A (no) |
PL (1) | PL355034A1 (no) |
PT (1) | PT1275647E (no) |
SI (1) | SI1275647T1 (no) |
TR (1) | TR200302001T4 (no) |
ZA (1) | ZA200205596B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004089410A1 (ja) * | 2003-04-03 | 2004-10-21 | Kyowa Hakko Kogyo Co., Ltd. | 神経因性疼痛の予防及び/または治療剤 |
MY141255A (en) * | 2003-12-11 | 2010-03-31 | Memory Pharm Corp | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2006000914A1 (en) * | 2004-06-22 | 2006-01-05 | Pfizer Products Inc. | Diazabicyclic histamine-3 receptor antagonists |
RU2442775C2 (ru) * | 2005-07-04 | 2012-02-20 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
EP2386554A1 (en) * | 2005-07-04 | 2011-11-16 | High Point Pharmaceuticals, LLC | Compounds active at the histamine H3 receptor |
EP1998620B1 (en) * | 2006-03-10 | 2011-01-12 | Neurogen Corporation | Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
KR100871691B1 (ko) | 2006-10-16 | 2008-12-05 | 삼성전자주식회사 | 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치 |
WO2018021447A1 (ja) | 2016-07-28 | 2018-02-01 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物 |
EP3744721A4 (en) | 2018-01-26 | 2021-11-10 | Shionogi & Co., Ltd | CONDENSED CYCLIC COMPOUND WITH ANTAGONISM TO DOPAMINE D3 RECEPTOR |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3388128A (en) * | 1965-09-03 | 1968-06-11 | Allan R. Day | Substituted 1, 4-diazabicyclo [4. 4. 9] decanes |
GB8518236D0 (en) * | 1985-07-19 | 1985-08-29 | Beecham Group Plc | Compounds |
AU5291793A (en) * | 1992-09-24 | 1994-04-12 | National Institutes Of Health | Aralkyl diazabicycloalkane derivatives for cns disorders |
US5731307A (en) * | 1994-09-30 | 1998-03-24 | Pfizer, Inc. | Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines |
US6231833B1 (en) * | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
AU773317B2 (en) * | 1999-07-19 | 2004-05-20 | Merck Canada Inc. | Pyrazinones, compositions containing such compounds |
-
2001
- 2001-07-12 FR FR0109260A patent/FR2827288B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-05 MX MXPA02006699A patent/MXPA02006699A/es active IP Right Grant
- 2002-07-10 JP JP2002201793A patent/JP3950018B2/ja not_active Expired - Fee Related
- 2002-07-11 DE DE60200089T patent/DE60200089T2/de not_active Expired - Fee Related
- 2002-07-11 DK DK02291745T patent/DK1275647T3/da active
- 2002-07-11 EP EP02291745A patent/EP1275647B1/fr not_active Expired - Lifetime
- 2002-07-11 NZ NZ520120A patent/NZ520120A/en unknown
- 2002-07-11 NO NO20023345A patent/NO322966B1/no not_active IP Right Cessation
- 2002-07-11 ES ES02291745T patent/ES2210219T3/es not_active Expired - Lifetime
- 2002-07-11 PT PT02291745T patent/PT1275647E/pt unknown
- 2002-07-11 SI SI200230005T patent/SI1275647T1/xx unknown
- 2002-07-11 AT AT02291745T patent/ATE254124T1/de not_active IP Right Cessation
- 2002-07-11 BR BR0202681-3A patent/BR0202681A/pt not_active IP Right Cessation
- 2002-07-11 TR TR2003/02001T patent/TR200302001T4/xx unknown
- 2002-07-11 EA EA200200663A patent/EA005160B1/ru not_active IP Right Cessation
- 2002-07-12 AU AU2002300094A patent/AU2002300094B2/en not_active Ceased
- 2002-07-12 HU HU0202282A patent/HUP0202282A3/hu unknown
- 2002-07-12 PL PL02355034A patent/PL355034A1/xx not_active Application Discontinuation
- 2002-07-12 KR KR10-2002-0040727A patent/KR100485020B1/ko not_active IP Right Cessation
- 2002-07-12 US US10/195,019 patent/US6992085B2/en not_active Expired - Fee Related
- 2002-07-12 CA CA002394027A patent/CA2394027C/fr not_active Expired - Fee Related
- 2002-07-12 CN CNB021241481A patent/CN1197863C/zh not_active Expired - Fee Related
- 2002-07-12 ZA ZA200205596A patent/ZA200205596B/xx unknown
- 2002-07-12 AR ARP020102607A patent/AR036166A1/es unknown
-
2003
- 2003-04-17 HK HK03102800A patent/HK1050682A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20022285L (no) | Nye <alfa>-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20003764D0 (no) | Nye <beta>-karbolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
NO20052683D0 (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20013254L (no) | Nye difenylureaforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske samensetninger som inneholder dem | |
NO20010522L (no) | Nye piperidin-4-sulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem | |
NO20023345D0 (no) | Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem | |
NO20026154D0 (no) | Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20014945L (no) | Nye cyklonbutendionforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20013206L (no) | Nye 1,1- og 1,2-disubstituerte cyklopropanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem | |
NO20010305D0 (no) | Nye benzensulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20021330L (no) | Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20021198D0 (no) | Nye isoindoloindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20031643L (no) | Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20016069D0 (no) | Nye bicykliske amino-pyrazinonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem | |
NO20023409D0 (no) | Nye N-benzylpiperazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20023389D0 (no) | Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20013710L (no) | Nye benzotiadiazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20035215L (no) | Tricykliske dihydrokinolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20021806L (no) | Nye pyrimidin-4-on-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20041313L (no) | Nye isokinolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20020262D0 (no) | Nye cykloheptenforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20011862L (no) | Nye heterocykloalkylbenzocyklobutan- og heteroarylbenzocyklobutanforbindelser, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20022794L (no) | Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20010801D0 (no) | Nye 6-amino- eller 6-hydroazino-sulfonyl-3- kinolynylfosfonsyreforbindelse, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
NO20010800L (no) | Nye 6-sulfamoyl-3-kinolylfosfonsyreforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |